PubMed:17317718 / 1169-1428 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycan-Motif

    {"project":"Glycan-Motif","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GlyCosmos6-Glycan-Motif-Image

    {"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"Glycan_Motif"}],"attributes":[{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    Glycosmos6-GlycoEpitope

    {"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"T4","span":{"begin":229,"end":234},"obj":"http://www.glycoepitope.jp/epitopes/AN0152"},{"id":"T5","span":{"begin":236,"end":242},"obj":"http://www.glycoepitope.jp/epitopes/AN0138"},{"id":"T6","span":{"begin":244,"end":247},"obj":"http://www.glycoepitope.jp/epitopes/AN0141"},{"id":"T7","span":{"begin":253,"end":258},"obj":"http://www.glycoepitope.jp/epitopes/AN0142"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GlyCosmos6-Glycan-Motif-Structure

    {"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T2","span":{"begin":229,"end":231},"obj":"http://www.uniprot.org/uniprot/O75390"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T6","span":{"begin":210,"end":217},"obj":"http://purl.obolibrary.org/obo/GO_0051923"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T3","span":{"begin":218,"end":228},"obj":"http://purl.obolibrary.org/obo/GO_0003823"},{"id":"T5","span":{"begin":154,"end":161},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T8","span":{"begin":154,"end":161},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T11","span":{"begin":154,"end":161},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T14","span":{"begin":154,"end":161},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":259},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":259},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":259},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GlycoBiology-Motifs

    {"project":"GlycoBiology-Motifs","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"http://rdf.glycoinfo.org/glycan/G00018MO"},{"id":"T7","span":{"begin":198,"end":217},"obj":"http://rdf.glycoinfo.org/glycan/G00018MO"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GlycoBiology-Epitope

    {"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T3","span":{"begin":198,"end":209},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"PD-GlycoEpitope-B_T5","span":{"begin":229,"end":234},"obj":"http://www.glycoepitope.jp/epitopes/AN0152"},{"id":"PD-GlycoEpitope-B_T7","span":{"begin":236,"end":242},"obj":"http://www.glycoepitope.jp/epitopes/AN0138"},{"id":"PD-GlycoEpitope-B_T9","span":{"begin":244,"end":247},"obj":"http://www.glycoepitope.jp/epitopes/AN0141"},{"id":"PD-GlycoEpitope-B_T12","span":{"begin":253,"end":258},"obj":"http://www.glycoepitope.jp/epitopes/AN0142"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    GlyCosmos15-Glycan

    {"project":"GlyCosmos15-Glycan","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"Glycan"}],"attributes":[{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G43702JT"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}

    Glycosmos15-GlycoEpitope

    {"project":"Glycosmos15-GlycoEpitope","denotations":[{"id":"T3","span":{"begin":198,"end":209},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T4","span":{"begin":229,"end":234},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T5","span":{"begin":236,"end":242},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T6","span":{"begin":244,"end":247},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T7","span":{"begin":253,"end":258},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0081"},{"id":"A4","pred":"glycoepitope_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/AN0152"},{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/AN0138"},{"id":"A6","pred":"glycoepitope_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/AN0141"},{"id":"A7","pred":"glycoepitope_id","subj":"T7","obj":"http://www.glycoepitope.jp/epitopes/AN0142"}],"text":"Microarrays of these structurally defined octasaccharide fractions were prepared using low picomole amounts of their lipid-derivatives to investigate the binding specificity of four commercial anti-chondroitin sulfate antibodies CS-56, MO-225, 2H6, and LY111."}